Enter inventor name

Georges E Lambelin

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent. Top assignees: Continental Pharma Incorporated, G.d. Searle & Company, Continental Pharma S.a.. Active years: 1976-1989.

USPTO Granted Patents = 13

% Patents Active = 100.0

CIPO Patents = 1

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 153(Granted Patents)

Location History:

Forest, BE (1985)
Brussels, BE (1976 - 1989)

Company Filing History:

9 out of 11

Continental Pharma Incorporated

patents

2 out of 1,323

G.d. Searle & Company

patents

1 out of 1

Continental Pharma S.a.

patent

4. 1 out of 1

Midit, Societe Fiduciaire

patent

Years Active: 1976-1989

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4853401 - Spiro-hydantoins as aldose reductase inhibitors (1989-08-01),

2. 4738979 - .alpha..sub.2 -blocking derivatives of imidazole (1988-04-19),

3. 4639468 - Derivatives of glycinamide, their preparation and their use (1987-01-27),

4. 4638070 - Heterocyclic amino-alcohol derivatives (1987-01-20),

5. 4562205 - Derivatives of 2-aminoacetic acid (1985-12-31),

6. 4534911 - Method for the preparation of p-butoxyphenylacetyl-hydroxamic acid in (1985-08-13),

7. 4507314 - Drug for treating affections provoked by a too high histamine level, of (1985-03-26),

8. 4474977 - Amino-alcohol derivatives (1984-10-02),

9. 4338330 - Benzimidazole derivatives, their use, and compositions containing these (1982-07-06),

10. 4285964 - Salts of (+)-catechine, their preparation and use, and compositions (1981-08-25),

11. 4268517 - Pharmaceutical composition and therapeutical method for treating (1981-05-19),

12. 4228187 - Alkyl and cycloalkylthiophenylalkylaminoalkanols, their salts and the (1980-10-14),

13. 3954871 - 1-(4-Alkylthiopheny)-2-substituted amino-alcohols and their salts (1976-05-04),

Title: The Innovative Contributions of Georges E Lambelin

Introduction

Georges E Lambelin is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on developing compounds that have therapeutic applications, particularly in the treatment of diabetes and related conditions.

Latest Patents

Among his latest patents, one notable invention is related to spiro-hydantoins as aldose reductase inhibitors. This invention involves spirohydantoins of a specific formula, which are designed to aid in the treatment and prevention of complications associated with diabetes and galactosemia. Another significant patent involves α2-blocking derivatives of imidazole, which includes a compound with various substituents that can be utilized in pharmaceutical applications.

Career Highlights

Throughout his career, Georges E Lambelin has worked with several prominent companies, including Continental Pharma Incorporated and G.D. Searle & Company. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Georges has collaborated with notable individuals in his field, including Joseph L Roba and Claude L Gillet. These partnerships have fostered a collaborative environment that has led to the successful development of various pharmaceutical innovations.

Conclusion

Georges E Lambelin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of diabetes and related health issues, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]